CHEETAH:A Prospective Multicenter Study to Evaluate the Safety and Performance of the CAT RX Aspiration Catheter in Patients with a High Thrombus Burden Acute Coronary Vessel Occlusion
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Coronary Vessel Occlusion
-
Age: Between 18 - 120 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Subjects presents to treating facility within 12 hours of symptom onset
- Subjects has high thrombus burden at coronary angiography, defined as TIMI thrombus grade 4 or 5 by physician visual estimate after the guidewire crosses the target lesion
- Subjects with frontline treatment with the Indigo® Aspiration System using the CAT RX Aspiration Catheter, prior to standard of care PCI
- Subjects who has target lesion is located in a native coronary artery
- Informed consent is obtained from either patient or legally authorized representative (LAR)
You may not be eligible for this study if the following are true:
-
- Subjects with a new onset of stroke symptoms and NIHSS > 2, prior to index procedure
- Subjects who are treated with fibrinolytic therapy for index coronary vessel occlusion
- Subjects who has life expectancy less than 6 months due to any comorbidities
- Subjects who are unwilling or unable to comply with protocol follow up schedule and/or based on the Investigator’s judgment the patient is not a good study candidate
- Subjects participating in another investigational drug or device study that may confound the results of this study.
- Subjects who are pregnant
If you are registered as a volunteer, please login to the dashboard to send referrals.